---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-171530"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:38:48.822253+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Vaccinex presents at Jefferies conference on KEYNOTE-B84 study; no new data disclosed

## Summary
- Presented at Jefferies Healthcare Conference on June 10, 2022 at 10:30 a.m. ET.
- Presentation covered the KEYNOTE-B84 study of pepinemab (anti-SEMA4D) in HNSCC.
- Filing does not include any new clinical data or financial results.
- Corporate slide deck furnished as Exhibit 99.1, available on company website.

## SEC filing metadata
- accession: 0001193125-22-171530
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312522171530/0001193125-22-171530-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312522171530/d314833d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-171530
- JSON: https://secwatch.observer/filing/0001193125-22-171530.json
- Plain text: https://secwatch.observer/filing/0001193125-22-171530.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.